Donna Bratton
Concepts (389)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Granulomatous Disease, Chronic | 8 | 2022 | 60 | 2.800 |
Why?
| Neutrophils | 15 | 2022 | 1163 | 1.940 |
Why?
| Apoptosis | 26 | 2022 | 2369 | 1.800 |
Why?
| Macrophages | 19 | 2022 | 1261 | 1.740 |
Why?
| Phagocytosis | 14 | 2018 | 350 | 1.690 |
Why?
| Lysophospholipids | 5 | 2013 | 65 | 1.460 |
Why?
| Receptors, G-Protein-Coupled | 4 | 2016 | 192 | 1.320 |
Why?
| Oxidants | 6 | 2014 | 112 | 1.260 |
Why?
| Thiazolidinediones | 3 | 2015 | 142 | 1.250 |
Why?
| Cell Cycle Proteins | 5 | 2016 | 552 | 1.160 |
Why?
| NADPH Oxidases | 9 | 2022 | 120 | 1.030 |
Why?
| Phagocytes | 5 | 2017 | 90 | 0.970 |
Why?
| Phosphatidylserines | 7 | 2013 | 87 | 0.870 |
Why?
| Macrophages, Peritoneal | 4 | 2013 | 91 | 0.840 |
Why?
| Mitochondria | 4 | 2015 | 751 | 0.830 |
Why?
| Inflammation | 12 | 2022 | 2481 | 0.760 |
Why?
| Interferon-gamma | 2 | 2016 | 722 | 0.700 |
Why?
| Signal Transduction | 15 | 2022 | 4521 | 0.680 |
Why?
| Inflammation Mediators | 6 | 2017 | 476 | 0.610 |
Why?
| Cytophagocytosis | 2 | 2022 | 10 | 0.580 |
Why?
| PPAR gamma | 3 | 2015 | 182 | 0.550 |
Why?
| Mice | 29 | 2022 | 14916 | 0.540 |
Why?
| Membrane Glycoproteins | 5 | 2014 | 429 | 0.530 |
Why?
| rac1 GTP-Binding Protein | 2 | 2013 | 56 | 0.510 |
Why?
| Animals | 38 | 2022 | 31761 | 0.510 |
Why?
| Mice, Inbred C57BL | 16 | 2022 | 4710 | 0.470 |
Why?
| Nitric Oxide | 3 | 2010 | 824 | 0.460 |
Why?
| Neutrophil Activation | 3 | 2013 | 94 | 0.450 |
Why?
| Colitis | 1 | 2016 | 223 | 0.450 |
Why?
| Peritonitis | 2 | 2013 | 76 | 0.440 |
Why?
| Macrophages, Alveolar | 7 | 2017 | 347 | 0.440 |
Why?
| Leukocyte Disorders | 1 | 2013 | 11 | 0.430 |
Why?
| Mice, Knockout | 10 | 2022 | 2582 | 0.420 |
Why?
| Eosinophils | 3 | 2004 | 278 | 0.400 |
Why?
| Lung | 7 | 2017 | 3546 | 0.400 |
Why?
| Receptors, Cell Surface | 3 | 2013 | 354 | 0.400 |
Why?
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2003 | 140 | 0.390 |
Why?
| NADPH Oxidase 2 | 5 | 2014 | 42 | 0.390 |
Why?
| Lipids | 2 | 2013 | 582 | 0.370 |
Why?
| Respiratory Mucosa | 1 | 2013 | 251 | 0.360 |
Why?
| Cells, Cultured | 10 | 2015 | 3890 | 0.340 |
Why?
| Hypersensitivity | 1 | 2013 | 254 | 0.330 |
Why?
| Asthma | 6 | 2012 | 2032 | 0.330 |
Why?
| Reperfusion Injury | 1 | 2011 | 254 | 0.320 |
Why?
| Pulmonary Disease, Chronic Obstructive | 3 | 2013 | 916 | 0.300 |
Why?
| Hypoglycemic Agents | 1 | 2015 | 1009 | 0.300 |
Why?
| Fundoplication | 1 | 2008 | 51 | 0.300 |
Why?
| Interleukin-4 | 1 | 2008 | 208 | 0.300 |
Why?
| Immunotherapy | 1 | 2011 | 475 | 0.290 |
Why?
| Membrane Microdomains | 2 | 2004 | 32 | 0.290 |
Why?
| Secretory Vesicles | 1 | 2007 | 24 | 0.290 |
Why?
| Epithelial Cells | 1 | 2013 | 955 | 0.280 |
Why?
| Acetates | 2 | 2004 | 95 | 0.280 |
Why?
| Disease Models, Animal | 6 | 2016 | 3542 | 0.280 |
Why?
| Reactive Oxygen Species | 5 | 2018 | 536 | 0.270 |
Why?
| Quinolines | 2 | 2004 | 129 | 0.270 |
Why?
| Transforming Growth Factor beta | 4 | 2013 | 449 | 0.270 |
Why?
| Gastroesophageal Reflux | 1 | 2008 | 234 | 0.250 |
Why?
| Calcium Signaling | 1 | 2007 | 213 | 0.250 |
Why?
| Flow Cytometry | 3 | 2016 | 1086 | 0.250 |
Why?
| Blotting, Western | 6 | 2013 | 1151 | 0.250 |
Why?
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 2004 | 64 | 0.230 |
Why?
| Phospholipid Transfer Proteins | 1 | 2004 | 11 | 0.230 |
Why?
| Acute Lung Injury | 2 | 2017 | 298 | 0.230 |
Why?
| Laparoscopy | 1 | 2008 | 388 | 0.230 |
Why?
| Anti-Asthmatic Agents | 2 | 2004 | 349 | 0.220 |
Why?
| Respiration | 1 | 2004 | 179 | 0.220 |
Why?
| Dinoprostone | 3 | 2013 | 184 | 0.220 |
Why?
| Health Resources | 1 | 2004 | 122 | 0.220 |
Why?
| Humans | 42 | 2022 | 114756 | 0.220 |
Why?
| Male | 20 | 2022 | 55579 | 0.210 |
Why?
| Jurkat Cells | 6 | 2012 | 128 | 0.200 |
Why?
| Dexamethasone | 2 | 2012 | 317 | 0.200 |
Why?
| Enzyme Activation | 4 | 2010 | 787 | 0.200 |
Why?
| Cell Differentiation | 2 | 2008 | 1699 | 0.200 |
Why?
| Mice, Transgenic | 7 | 2022 | 1951 | 0.200 |
Why?
| Membrane Proteins | 2 | 2008 | 1022 | 0.200 |
Why?
| Monocytes | 3 | 2014 | 503 | 0.200 |
Why?
| Polyamines | 1 | 2022 | 35 | 0.200 |
Why?
| Interleukin-15 | 1 | 2002 | 74 | 0.200 |
Why?
| Adjuvants, Immunologic | 1 | 2003 | 206 | 0.190 |
Why?
| Superoxides | 4 | 2018 | 214 | 0.190 |
Why?
| Lymph Nodes | 3 | 2016 | 423 | 0.190 |
Why?
| Tumor Necrosis Factor-alpha | 4 | 2014 | 1134 | 0.180 |
Why?
| Cytokines | 5 | 2018 | 1843 | 0.180 |
Why?
| Eicosanoids | 2 | 2013 | 54 | 0.180 |
Why?
| Dermatitis, Atopic | 2 | 2017 | 307 | 0.170 |
Why?
| Carrier Proteins | 1 | 2004 | 696 | 0.170 |
Why?
| Zymosan | 2 | 2010 | 63 | 0.170 |
Why?
| NF-kappa B | 2 | 2006 | 636 | 0.160 |
Why?
| Autoimmunity | 1 | 2005 | 814 | 0.160 |
Why?
| Proto-Oncogene Proteins | 2 | 2017 | 610 | 0.160 |
Why?
| src-Family Kinases | 2 | 2013 | 88 | 0.150 |
Why?
| Female | 17 | 2022 | 59507 | 0.150 |
Why?
| Lung Diseases | 1 | 2004 | 696 | 0.150 |
Why?
| Cytotoxicity, Immunologic | 1 | 2018 | 195 | 0.150 |
Why?
| Gene Expression Regulation | 3 | 2013 | 2321 | 0.150 |
Why?
| c-Mer Tyrosine Kinase | 1 | 2017 | 43 | 0.150 |
Why?
| Cell Communication | 2 | 2011 | 279 | 0.140 |
Why?
| Angioedema | 1 | 2017 | 16 | 0.140 |
Why?
| Superoxide Dismutase | 3 | 2010 | 305 | 0.140 |
Why?
| Rhinitis, Allergic, Seasonal | 1 | 2017 | 32 | 0.140 |
Why?
| Proteins | 1 | 2003 | 912 | 0.140 |
Why?
| Cell-Derived Microparticles | 1 | 2017 | 57 | 0.140 |
Why?
| Mycobacterium abscessus | 1 | 2018 | 98 | 0.130 |
Why?
| Mononuclear Phagocyte System | 1 | 2016 | 12 | 0.130 |
Why?
| Dextran Sulfate | 1 | 2016 | 70 | 0.130 |
Why?
| Cell Membrane | 2 | 2013 | 679 | 0.130 |
Why?
| Face | 1 | 2017 | 168 | 0.130 |
Why?
| Group IV Phospholipases A2 | 2 | 2013 | 45 | 0.130 |
Why?
| Myeloid Cells | 1 | 2016 | 127 | 0.130 |
Why?
| Receptor Protein-Tyrosine Kinases | 1 | 2017 | 227 | 0.130 |
Why?
| CD36 Antigens | 2 | 2013 | 37 | 0.120 |
Why?
| Severity of Illness Index | 3 | 2013 | 2539 | 0.120 |
Why?
| Metalloproteases | 1 | 2014 | 37 | 0.120 |
Why?
| Cromolyn Sodium | 2 | 2004 | 13 | 0.110 |
Why?
| Cyclic AMP | 2 | 2013 | 225 | 0.110 |
Why?
| Protein Biosynthesis | 2 | 2008 | 385 | 0.110 |
Why?
| Quorum Sensing | 1 | 2014 | 71 | 0.110 |
Why?
| Membrane Lipids | 2 | 2005 | 87 | 0.110 |
Why?
| MAP Kinase Signaling System | 2 | 2013 | 276 | 0.110 |
Why?
| Endothelial Progenitor Cells | 1 | 2013 | 18 | 0.110 |
Why?
| Candida albicans | 1 | 2013 | 50 | 0.110 |
Why?
| Lupus Erythematosus, Systemic | 2 | 2016 | 221 | 0.110 |
Why?
| Virulence Factors | 1 | 2014 | 139 | 0.110 |
Why?
| Glycoproteins | 2 | 2013 | 304 | 0.110 |
Why?
| Phospholipids | 2 | 2005 | 197 | 0.110 |
Why?
| Pharmaceutical Preparations | 1 | 2014 | 168 | 0.100 |
Why?
| Transforming Growth Factor beta1 | 1 | 2013 | 153 | 0.100 |
Why?
| Mycobacterium Infections | 1 | 2013 | 61 | 0.100 |
Why?
| Pseudomonas aeruginosa | 1 | 2014 | 298 | 0.100 |
Why?
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2012 | 66 | 0.100 |
Why?
| Ischemia | 1 | 2014 | 362 | 0.100 |
Why?
| Mycobacterium | 1 | 2013 | 103 | 0.100 |
Why?
| Mycoplasma pneumoniae | 1 | 2011 | 28 | 0.090 |
Why?
| Phospholipases A2, Calcium-Independent | 1 | 2011 | 4 | 0.090 |
Why?
| Staphylococcus aureus | 1 | 2014 | 385 | 0.090 |
Why?
| Pneumonia, Mycoplasma | 1 | 2011 | 30 | 0.090 |
Why?
| Prostaglandin-Endoperoxide Synthases | 1 | 2011 | 58 | 0.090 |
Why?
| Adenylyl Cyclases | 1 | 2011 | 82 | 0.090 |
Why?
| Pulmonary Emphysema | 1 | 2013 | 268 | 0.090 |
Why?
| Hematopoietic Stem Cells | 1 | 2013 | 345 | 0.090 |
Why?
| Cell Line | 5 | 2012 | 2639 | 0.090 |
Why?
| Spectrometry, Mass, Electrospray Ionization | 1 | 2011 | 162 | 0.090 |
Why?
| Complement C3 | 1 | 2011 | 189 | 0.090 |
Why?
| Receptors, Immunologic | 2 | 2015 | 201 | 0.090 |
Why?
| Oxidative Stress | 3 | 2012 | 1084 | 0.090 |
Why?
| Transcription, Genetic | 3 | 2017 | 1316 | 0.090 |
Why?
| Leukocyte Common Antigens | 2 | 2013 | 76 | 0.080 |
Why?
| CD47 Antigen | 2 | 2006 | 21 | 0.080 |
Why?
| Gene Expression Profiling | 4 | 2017 | 1521 | 0.080 |
Why?
| Smoke | 1 | 2010 | 123 | 0.080 |
Why?
| Anti-Inflammatory Agents | 1 | 2013 | 450 | 0.080 |
Why?
| Calreticulin | 2 | 2006 | 24 | 0.080 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2012 | 498 | 0.080 |
Why?
| Phosphoproteins | 1 | 2011 | 299 | 0.080 |
Why?
| Adolescent | 5 | 2015 | 17808 | 0.080 |
Why?
| Gene Deletion | 1 | 2010 | 356 | 0.080 |
Why?
| Tandem Mass Spectrometry | 1 | 2011 | 413 | 0.080 |
Why?
| Administration, Inhalation | 3 | 2004 | 642 | 0.080 |
Why?
| Hypoxia | 1 | 2014 | 957 | 0.080 |
Why?
| Angiogenic Proteins | 1 | 2008 | 18 | 0.080 |
Why?
| Idiopathic Pulmonary Fibrosis | 1 | 2014 | 505 | 0.070 |
Why?
| Cell Adhesion Molecules, Neuronal | 1 | 2008 | 35 | 0.070 |
Why?
| Allergens | 2 | 2017 | 413 | 0.070 |
Why?
| Cyclopropanes | 2 | 2004 | 81 | 0.070 |
Why?
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2007 | 14 | 0.070 |
Why?
| Immunoglobulin G | 1 | 2011 | 774 | 0.070 |
Why?
| Child | 6 | 2017 | 18352 | 0.070 |
Why?
| Recombinant Proteins | 1 | 2010 | 1233 | 0.070 |
Why?
| Type C Phospholipases | 1 | 2007 | 65 | 0.070 |
Why?
| Phospholipases A | 1 | 2007 | 101 | 0.070 |
Why?
| Cell Death | 1 | 2008 | 322 | 0.070 |
Why?
| Sulfides | 2 | 2004 | 94 | 0.070 |
Why?
| Reproducibility of Results | 3 | 2017 | 2763 | 0.070 |
Why?
| Fibroblasts | 2 | 2008 | 838 | 0.070 |
Why?
| Antibodies | 1 | 2008 | 371 | 0.070 |
Why?
| Respiratory Function Tests | 1 | 2008 | 524 | 0.070 |
Why?
| Antigens, Surface | 1 | 2006 | 146 | 0.060 |
Why?
| Immunity, Innate | 1 | 2011 | 723 | 0.060 |
Why?
| Oxidation-Reduction | 1 | 2008 | 927 | 0.060 |
Why?
| Administration, Oral | 2 | 2004 | 731 | 0.060 |
Why?
| Mitogen-Activated Protein Kinases | 2 | 2004 | 278 | 0.060 |
Why?
| Cell Lineage | 2 | 2017 | 310 | 0.060 |
Why?
| Adult | 6 | 2016 | 30548 | 0.060 |
Why?
| cdc42 GTP-Binding Protein | 1 | 2004 | 24 | 0.060 |
Why?
| Child, Preschool | 4 | 2008 | 9079 | 0.060 |
Why?
| beta-Cyclodextrins | 1 | 2004 | 28 | 0.060 |
Why?
| Chemotaxis, Leukocyte | 1 | 2004 | 129 | 0.060 |
Why?
| Factor Va | 1 | 2004 | 3 | 0.060 |
Why?
| Pinocytosis | 1 | 2004 | 10 | 0.060 |
Why?
| Annexin A5 | 1 | 2004 | 22 | 0.060 |
Why?
| Cholera Toxin | 1 | 2004 | 27 | 0.060 |
Why?
| Phosphorylcholine | 1 | 2004 | 17 | 0.060 |
Why?
| Breath Tests | 1 | 2004 | 82 | 0.060 |
Why?
| Phosphoserine | 1 | 2004 | 33 | 0.060 |
Why?
| Detergents | 1 | 2004 | 41 | 0.060 |
Why?
| Isoquinolines | 1 | 2004 | 36 | 0.060 |
Why?
| Subcellular Fractions | 1 | 2004 | 78 | 0.060 |
Why?
| Autoantibodies | 1 | 2011 | 1350 | 0.060 |
Why?
| Transcriptional Activation | 1 | 2005 | 337 | 0.060 |
Why?
| Antioxidants | 2 | 2007 | 530 | 0.050 |
Why?
| Alkaline Phosphatase | 1 | 2004 | 143 | 0.050 |
Why?
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2003 | 12 | 0.050 |
Why?
| Endocytosis | 1 | 2004 | 149 | 0.050 |
Why?
| Phosphatidylinositol 3-Kinases | 2 | 2022 | 330 | 0.050 |
Why?
| Dose-Response Relationship, Immunologic | 1 | 2003 | 76 | 0.050 |
Why?
| Intracellular Membranes | 1 | 2003 | 73 | 0.050 |
Why?
| Cloning, Molecular | 1 | 2004 | 524 | 0.050 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2004 | 213 | 0.050 |
Why?
| Reference Values | 1 | 2004 | 742 | 0.050 |
Why?
| Middle Aged | 5 | 2015 | 26757 | 0.050 |
Why?
| Permeability | 1 | 2003 | 148 | 0.050 |
Why?
| JNK Mitogen-Activated Protein Kinases | 1 | 2003 | 144 | 0.050 |
Why?
| Membrane Potentials | 1 | 2003 | 249 | 0.050 |
Why?
| Family Relations | 1 | 2002 | 85 | 0.050 |
Why?
| Spermine | 1 | 2022 | 26 | 0.050 |
Why?
| Spermidine | 1 | 2022 | 17 | 0.050 |
Why?
| Sputum | 2 | 2014 | 285 | 0.050 |
Why?
| Leukocyte Elastase | 1 | 2002 | 79 | 0.050 |
Why?
| Transfection | 1 | 2004 | 870 | 0.050 |
Why?
| Biofilms | 2 | 2014 | 223 | 0.050 |
Why?
| Phosphoric Monoester Hydrolases | 1 | 2001 | 54 | 0.050 |
Why?
| Protein Structure, Tertiary | 1 | 2004 | 797 | 0.050 |
Why?
| Protein Binding | 2 | 2004 | 1896 | 0.050 |
Why?
| Patients | 1 | 2002 | 162 | 0.050 |
Why?
| Adrenal Cortex Hormones | 1 | 2004 | 498 | 0.050 |
Why?
| Immunomodulation | 1 | 2022 | 84 | 0.050 |
Why?
| Healthy Volunteers | 1 | 2022 | 197 | 0.050 |
Why?
| Bronchiectasis | 1 | 2002 | 106 | 0.050 |
Why?
| Double-Blind Method | 1 | 2004 | 1662 | 0.040 |
Why?
| Young Adult | 1 | 2015 | 10463 | 0.040 |
Why?
| Obesity | 1 | 2012 | 2513 | 0.040 |
Why?
| Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 797 | 0.040 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 928 | 0.040 |
Why?
| Dual Specificity Phosphatase 1 | 2 | 2012 | 28 | 0.040 |
Why?
| Cyclooxygenase 2 | 2 | 2013 | 164 | 0.040 |
Why?
| Time Factors | 2 | 2014 | 6124 | 0.040 |
Why?
| Cystic Fibrosis | 2 | 2014 | 955 | 0.040 |
Why?
| Patient Satisfaction | 1 | 2003 | 583 | 0.040 |
Why?
| Gene Expression | 2 | 2014 | 1420 | 0.040 |
Why?
| Cell Proliferation | 2 | 2017 | 2196 | 0.040 |
Why?
| Intracellular Space | 1 | 2018 | 68 | 0.040 |
Why?
| Extracellular Traps | 1 | 2018 | 40 | 0.040 |
Why?
| Extracellular Space | 1 | 2018 | 117 | 0.040 |
Why?
| Microbial Viability | 1 | 2018 | 79 | 0.040 |
Why?
| Mice, Inbred BALB C | 2 | 2013 | 1151 | 0.040 |
Why?
| Pollen | 1 | 2017 | 24 | 0.040 |
Why?
| Antigens, CD | 2 | 2013 | 443 | 0.040 |
Why?
| Histamine Antagonists | 1 | 2017 | 20 | 0.040 |
Why?
| DNA | 1 | 2004 | 1351 | 0.040 |
Why?
| Age Factors | 1 | 2004 | 2890 | 0.040 |
Why?
| Pruritus | 1 | 2017 | 60 | 0.040 |
Why?
| Trees | 1 | 2017 | 61 | 0.030 |
Why?
| Antigens, Plant | 1 | 2017 | 47 | 0.030 |
Why?
| Arachidonic Acid | 2 | 2007 | 116 | 0.030 |
Why?
| Organ Specificity | 1 | 2017 | 268 | 0.030 |
Why?
| Lymphohistiocytosis, Hemophagocytic | 1 | 2016 | 28 | 0.030 |
Why?
| Steroids | 1 | 2017 | 145 | 0.030 |
Why?
| Bone Marrow Cells | 1 | 2017 | 267 | 0.030 |
Why?
| Caregivers | 1 | 2002 | 717 | 0.030 |
Why?
| rho GTP-Binding Proteins | 2 | 2007 | 61 | 0.030 |
Why?
| Transplantation Chimera | 1 | 2015 | 51 | 0.030 |
Why?
| Up-Regulation | 2 | 2010 | 812 | 0.030 |
Why?
| Sequence Analysis, RNA | 1 | 2017 | 388 | 0.030 |
Why?
| Prolyl Hydroxylases | 1 | 2014 | 4 | 0.030 |
Why?
| Cadaver | 1 | 2016 | 299 | 0.030 |
Why?
| Cellular Microenvironment | 1 | 2015 | 78 | 0.030 |
Why?
| Tobramycin | 1 | 2014 | 47 | 0.030 |
Why?
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2014 | 7 | 0.030 |
Why?
| Treatment Outcome | 1 | 2008 | 9089 | 0.030 |
Why?
| Tacrolimus Binding Proteins | 1 | 2014 | 16 | 0.030 |
Why?
| Hydroxyproline | 1 | 2014 | 22 | 0.030 |
Why?
| Drug Resistance, Multiple, Bacterial | 1 | 2014 | 63 | 0.030 |
Why?
| Bone Marrow Transplantation | 1 | 2015 | 241 | 0.030 |
Why?
| Lung Compliance | 1 | 2014 | 47 | 0.030 |
Why?
| Dendritic Cells | 1 | 2017 | 436 | 0.030 |
Why?
| AC133 Antigen | 1 | 2013 | 19 | 0.030 |
Why?
| Azithromycin | 1 | 2014 | 80 | 0.030 |
Why?
| fas Receptor | 1 | 2014 | 92 | 0.030 |
Why?
| Colony-Forming Units Assay | 1 | 2013 | 89 | 0.030 |
Why?
| Leukotriene C4 | 1 | 2013 | 12 | 0.030 |
Why?
| Antigens, CD34 | 1 | 2013 | 89 | 0.030 |
Why?
| Remission Induction | 1 | 2014 | 233 | 0.030 |
Why?
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2013 | 86 | 0.030 |
Why?
| Microbial Sensitivity Tests | 1 | 2014 | 301 | 0.030 |
Why?
| Autoimmune Diseases | 1 | 2016 | 391 | 0.030 |
Why?
| Receptors, Transforming Growth Factor beta | 1 | 2013 | 52 | 0.030 |
Why?
| Mycobacterium Infections, Nontuberculous | 1 | 2018 | 333 | 0.030 |
Why?
| Models, Biological | 3 | 2006 | 1630 | 0.030 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 743 | 0.030 |
Why?
| PPAR delta | 1 | 2012 | 6 | 0.030 |
Why?
| Cell Count | 1 | 2013 | 305 | 0.030 |
Why?
| Vital Capacity | 1 | 2013 | 256 | 0.030 |
Why?
| Parents | 3 | 2008 | 1190 | 0.030 |
Why?
| Pseudomonas Infections | 1 | 2014 | 184 | 0.030 |
Why?
| Receptors, Chemokine | 1 | 2012 | 43 | 0.030 |
Why?
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 225 | 0.030 |
Why?
| Metabolomics | 1 | 2017 | 527 | 0.030 |
Why?
| Antibodies, Monoclonal | 2 | 2012 | 1270 | 0.030 |
Why?
| Pulmonary Alveoli | 1 | 2015 | 372 | 0.030 |
Why?
| Epoprostenol | 1 | 2013 | 133 | 0.030 |
Why?
| Bleomycin | 1 | 2014 | 228 | 0.030 |
Why?
| Cell Movement | 1 | 2016 | 867 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 316 | 0.030 |
Why?
| Forced Expiratory Volume | 1 | 2013 | 476 | 0.030 |
Why?
| In Vitro Techniques | 2 | 2006 | 1013 | 0.020 |
Why?
| Pneumonia | 1 | 2017 | 566 | 0.020 |
Why?
| Quality of Life | 1 | 2002 | 2358 | 0.020 |
Why?
| Doxycycline | 1 | 2012 | 55 | 0.020 |
Why?
| Lipopolysaccharides | 2 | 2006 | 812 | 0.020 |
Why?
| Aldehydes | 1 | 2012 | 142 | 0.020 |
Why?
| Immunity, Cellular | 1 | 2013 | 248 | 0.020 |
Why?
| Receptors, Glucocorticoid | 1 | 2012 | 130 | 0.020 |
Why?
| Emphysema | 1 | 2012 | 107 | 0.020 |
Why?
| Chemokine CXCL2 | 1 | 2010 | 37 | 0.020 |
Why?
| Onium Compounds | 1 | 2010 | 10 | 0.020 |
Why?
| Pyrroles | 1 | 2012 | 183 | 0.020 |
Why?
| Recovery of Function | 1 | 2014 | 572 | 0.020 |
Why?
| Indoles | 1 | 2012 | 306 | 0.020 |
Why?
| Phenotype | 1 | 2017 | 2812 | 0.020 |
Why?
| Phosphorylation | 2 | 2004 | 1571 | 0.020 |
Why?
| Autoantigens | 1 | 2011 | 396 | 0.020 |
Why?
| 3T3 Cells | 1 | 2008 | 140 | 0.020 |
Why?
| Peptides | 1 | 2013 | 848 | 0.020 |
Why?
| Glucocorticoids | 1 | 2012 | 532 | 0.020 |
Why?
| Statistics, Nonparametric | 1 | 2008 | 386 | 0.020 |
Why?
| Phospholipases A2 | 1 | 2007 | 76 | 0.020 |
Why?
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2007 | 33 | 0.020 |
Why?
| Enzyme Inhibitors | 1 | 2010 | 751 | 0.020 |
Why?
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2007 | 72 | 0.020 |
Why?
| Metalloporphyrins | 1 | 2007 | 104 | 0.020 |
Why?
| Collectins | 1 | 2006 | 12 | 0.020 |
Why?
| Leukemia, Plasma Cell | 1 | 2006 | 5 | 0.020 |
Why?
| RNA, Messenger | 1 | 2013 | 2557 | 0.020 |
Why?
| Protein Phosphatase 1 | 1 | 2006 | 28 | 0.020 |
Why?
| Smad2 Protein | 1 | 2006 | 33 | 0.020 |
Why?
| Immediate-Early Proteins | 1 | 2006 | 52 | 0.020 |
Why?
| Phosphoprotein Phosphatases | 1 | 2006 | 64 | 0.020 |
Why?
| Microscopy, Video | 1 | 2005 | 26 | 0.020 |
Why?
| Hydrogen Peroxide | 1 | 2007 | 287 | 0.020 |
Why?
| Nitric Oxide Synthase Type II | 1 | 2006 | 157 | 0.020 |
Why?
| Anti-Bacterial Agents | 1 | 2014 | 1477 | 0.020 |
Why?
| Genes, Reporter | 1 | 2006 | 257 | 0.020 |
Why?
| Protein Tyrosine Phosphatases | 1 | 2006 | 147 | 0.020 |
Why?
| Embryo, Mammalian | 1 | 2005 | 214 | 0.020 |
Why?
| Heterozygote | 1 | 2005 | 251 | 0.020 |
Why?
| Cyclodextrins | 1 | 2004 | 8 | 0.010 |
Why?
| Bronchial Provocation Tests | 1 | 2004 | 53 | 0.010 |
Why?
| Thorax | 1 | 2004 | 40 | 0.010 |
Why?
| rac GTP-Binding Proteins | 1 | 2004 | 34 | 0.010 |
Why?
| Genes, MHC Class II | 1 | 2004 | 70 | 0.010 |
Why?
| Ligands | 1 | 2006 | 564 | 0.010 |
Why?
| bcl-2-Associated X Protein | 1 | 2004 | 45 | 0.010 |
Why?
| Antigen Presentation | 1 | 2004 | 189 | 0.010 |
Why?
| p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 262 | 0.010 |
Why?
| Cytoplasm | 1 | 2004 | 255 | 0.010 |
Why?
| Infant | 2 | 2008 | 7935 | 0.010 |
Why?
| Phosphates | 1 | 2004 | 158 | 0.010 |
Why?
| Cohort Studies | 1 | 2012 | 4901 | 0.010 |
Why?
| Biomarkers | 1 | 2012 | 3416 | 0.010 |
Why?
| Cholesterol | 1 | 2004 | 368 | 0.010 |
Why?
| Albuterol | 1 | 2003 | 102 | 0.010 |
Why?
| Protein Transport | 1 | 2004 | 396 | 0.010 |
Why?
| Actins | 1 | 2004 | 381 | 0.010 |
Why?
| Cell Division | 1 | 2004 | 759 | 0.010 |
Why?
| Inositol Phosphates | 1 | 2001 | 23 | 0.010 |
Why?
| Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases | 1 | 2001 | 13 | 0.010 |
Why?
| Precipitin Tests | 1 | 2001 | 88 | 0.010 |
Why?
| Foster Home Care | 1 | 2002 | 70 | 0.010 |
Why?
| Receptors, IgG | 1 | 2002 | 67 | 0.010 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2004 | 399 | 0.010 |
Why?
| Jumonji Domain-Containing Histone Demethylases | 1 | 2002 | 59 | 0.010 |
Why?
| Cross-Over Studies | 1 | 2003 | 440 | 0.010 |
Why?
| Bronchodilator Agents | 1 | 2003 | 240 | 0.010 |
Why?
| Aged | 2 | 2013 | 19094 | 0.010 |
Why?
| Parent-Child Relations | 1 | 2002 | 235 | 0.010 |
Why?
| Acute Disease | 1 | 2002 | 912 | 0.010 |
Why?
| Stress, Physiological | 1 | 2002 | 379 | 0.010 |
Why?
| Patient Compliance | 1 | 2003 | 525 | 0.010 |
Why?
| Lipid Metabolism | 1 | 2001 | 446 | 0.010 |
Why?
| Oxygen | 1 | 2001 | 853 | 0.010 |
Why?
| Patient Discharge | 1 | 2002 | 769 | 0.010 |
Why?
| Incidence | 1 | 2002 | 2312 | 0.010 |
Why?
| Anxiety | 1 | 2002 | 842 | 0.010 |
Why?
| Depression | 1 | 2002 | 1133 | 0.010 |
Why?
| Hospitalization | 1 | 2002 | 1752 | 0.010 |
Why?
| Emergency Service, Hospital | 1 | 2002 | 1812 | 0.010 |
Why?
| Surveys and Questionnaires | 1 | 2002 | 4625 | 0.010 |
Why?
|
|
Bratton's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|